Join to View Full Profile
222 E 41st StFl 20New York, NY 10017
Phone+1 212-263-0705
Dr. Charytan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2001 - 2004- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1998 - 2001
New York University School of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2018 - 2025
MA State Medical License 2001 - 2022
FL State Medical License 2014 - 2016
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD Start of enrollment: 2017 Aug 28
- Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A Start of enrollment: 2018 Nov 30
- Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study B Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concent...David M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, John P Middleton, Charles A Herzog
Kidney International. 2025-06-01 - Neighborhood Built Environment and Home Dialysis Utilization: Varying Patterns by Urbanicity-Dependent Patterns and Implications for Policy.Byoungjun Kim, Yiting Li, Myeonggyun Lee, Sunjae Bae, Matthew F Blum
American Journal of Kidney Diseases. 2025-06-01 - Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, a Multi-Dialysis Center 2 × 2 Factorial Block-Randomized Controlled Trial.Nidhi Ghildayal, Yi Liu, Jingyao Hong, Yiting Li, Xiaomeng Chen
American Journal of Nephrology. 2025-05-10
Journal Articles
- Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
- Nephrology and COVID-19Wolfgang C Winkelmayer, Pascale Khairallah, David M Charytan, JAMA
- Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD (SPin-D): A Randomized, Placebo-Controlled, Multiple Dosage TrialDavid M Charytan, Jonathan Himmelfarb, Adriana M Hung, Rajnish Mehrotra, Shailendra Sharma, Daniel E Weiner, Alan S Kliger, Laura M Dember, Kidney International
- Join now to see all
Authored Content
- The Authors ReplyJuly 2018
Press Mentions
How Would Eliminating Race-Based Adjustments in Estimates of Kidney Function Impact Clinical Trials?January 21st, 2022- Is “Patient Activation Measure” Relevant for Adults on Dialysis?August 30th, 2021
- Mortality & Progression to ESKD After Heart Surgeries in Patients with CKDAugust 16th, 2021
- Join now to see all
Grant Support
- Deep learning on ECGs to improve outcomes in patients on dialysisICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Deep learning on ECGs to improve outcomes in patients on dialysisICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Deep learning on ECGs to improve outcomes in patients on dialysisICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Deep learning on ECGs to improve outcomes in patients on dialysisICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- Safety and Efficacy of Empagliflozin Main intenance HD (SEED)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2026
- Safety and Efficacy of Empagliflozin Main intenance HD (SEED)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2026
- Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk FactorNEW YORK UNIVERSITY SCHOOL OF MEDICINE2021–2026
- Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk FactorNEW YORK UNIVERSITY SCHOOL OF MEDICINE2021–2026
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
